Sotalol for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Sotalol is a prescription heart medication used off-label in horses to help manage certain abnormal heart rhythms, also called arrhythmias. It belongs to the class III antiarrhythmic group, but it also acts as a nonselective beta blocker. That means it can both slow the heart's response to adrenaline and change how electrical signals move through heart tissue.

In horses, oral antiarrhythmic options are limited, so sotalol is one of the medications your vet may consider when a rhythm problem needs longer-term medical management rather than emergency hospital treatment alone. Research in healthy horses found that oral sotalol increased the QT interval and effective refractory period, which are electrical effects that may help reduce some arrhythmias.

This is not a medication pet parents should start, stop, or adjust on their own. Horses with rhythm problems often need an ECG, sometimes echocardiography, and repeat monitoring to decide whether sotalol is appropriate and whether the response is helping more than harming.

Sotalol is used most often when your vet is trying to control clinically important arrhythmias over days to weeks, not just minutes to hours. In equine practice, that usually means selected horses with ventricular premature complexes, ventricular tachyarrhythmias, or other persistent rhythm disturbances that continue after the horse is stabilized.

Some cardiology references also discuss sotalol as part of management around atrial fibrillation, especially when the goal is to influence electrical refractoriness before conversion. Still, it is not the right fit for every horse with atrial fibrillation, and it is not a substitute for a full cardiac workup.

Your vet may recommend sotalol when the rhythm problem affects performance, safety, or overall cardiovascular stability, or when there is concern that repeated abnormal beats could progress. The exact reason matters, because treatment choices differ for isolated premature beats, sustained ventricular arrhythmias, atrial fibrillation, and horses with underlying structural heart disease.

Sotalol dosing in horses should be individualized by your vet, but published equine studies have evaluated oral dosing at 2, 3, and 4 mg/kg by mouth every 12 hours. In one pharmacokinetic study, a single oral dose of 1 mg/kg had about 48% oral bioavailability, reached peak blood levels in about 0.94 hours, and had a mean elimination half-life of about 15.24 hours.

In practical terms, many horses receiving sotalol are dosed twice daily, with the exact milligram amount based on body weight, tablet size, the arrhythmia being treated, and ECG response. For example, a 500 kg horse would receive a very different total dose than a 350 kg horse, so pet parents should never estimate from another horse's prescription.

Your vet may start at a more conservative dose and recheck an ECG before making changes. Monitoring matters because the goal is not only to reduce abnormal beats, but also to avoid excessive slowing of the heart or unwanted electrical changes such as marked QT prolongation. If your horse has kidney disease, heart failure, low heart rate, or conduction disease, your vet may choose a different plan or more cautious monitoring.

Call your vet promptly if your horse seems weak, unusually quiet, exercise intolerant, unsteady, or has a fainting-like episode after starting sotalol. Because this drug slows electrical conduction and blocks beta receptors, the biggest concerns are bradycardia (an overly slow heart rate), worsening conduction problems, low blood pressure, and proarrhythmia, meaning a medication-triggered worsening of the rhythm problem.

Published equine studies reported transient sweating or transpiration as the main observed short-term adverse effect, with no major adverse effects seen in small groups of healthy horses at studied doses. That is reassuring, but it does not guarantee safety in horses that already have heart disease, electrolyte abnormalities, or poor perfusion.

General veterinary references also list tiredness, poor appetite, collapse, coughing, breathing difficulty, nausea, and vomiting as possible adverse effects across species. Horses may show these differently than dogs or cats, so any new lethargy, reduced performance, respiratory effort, or collapse should be treated as important. See your vet immediately if your horse collapses, has labored breathing, or seems dramatically weaker.

Sotalol can interact with other medications that slow the heart, lower blood pressure, or prolong the QT interval. That includes some antiarrhythmics, calcium channel blockers, macrolide antibiotics, fluoroquinolones, digoxin, and certain sedatives or phenothiazines. Combining rhythm drugs can be useful in selected cases, but only when your vet is intentionally building that plan and monitoring the horse closely.

Examples of medications your vet will want to review carefully include digoxin, lidocaine, quinidine, propranolol, acepromazine, azithromycin, clarithromycin, erythromycin, and some diuretics. Diuretics matter because electrolyte shifts, especially low potassium or magnesium, can increase arrhythmia risk.

Always tell your vet about every prescription, supplement, electrolyte product, and ulcer or pain medication your horse receives. Even if a product seems unrelated to the heart, it may still affect hydration status, kidney handling of the drug, or the horse's electrical stability.